Written question asked by Gareth Thomas (Labour) on Wednesday, 12 October 2022, in the House of Commons. It was due for an answer on Monday, 17 October 2022. It was answered by Greg Hands (Conservative) on Monday, 17 October 2022 on behalf of the Department for International Trade.
TRIPS Agreement: Coronavirus
- Question
-
To ask the Secretary of State for International Trade, what assessment she had made of the potential merits of including (a) covid-19 treatments, and (b) diagnostics in the Trade-Related Aspects of Intellectual Property Rights waiver negotiation.
- Answer
-
The UK is engaging in the ongoing discussions taking place in the World Trade Organization, as Members consider extending the TRIPS Decision to COVID-19 therapeutics and diagnostics.
The UK approach will be evidence based.
Secondary information
- Type
- Written question
- Reference
- 61708
- Session
- 2022-23
- Related items
- Subjects
- Diagnosis Medical treatments TRIPS Agreement Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-12-16 15:44:47 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/61708
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/61708
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/61708